PHARMABRIDGE
Timeline
40 events since 2004Board
Capital
Filings
Financial
End
Address
Other
200420062008201020122014201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Dissolution with immediate closure of the liquidationDissolved and wound up in a single deed · Books and records kept in Ghent (5 years) · (director) and (director) resign · General meeting of 26-10-20269 points ▸
- General meeting of 26-10-2026
- Net-asset statement, 31-07-2026
- resigns as director
- resigns as director
- Discharge granted to
- Discharge granted to
- Power of attorney granted to
- Discharge granted to
- Board meeting of 23-10-2026
- The deed holds 14 more points.
Annual accounts 2025 filed NBBmicro format · 7 days before the deadline
2025
Listed in the Peppol Directory
Annual accounts 2024 filed PDFmicro format · 48 days before the deadline
2024
Liquidity more than 7 times current ratio 117.64 The current ratio rises from 15.79 to 117.64. Short-term debt falls from €22,381 to €3,227.
Annual accounts 2023 filed PDFmicro format · 34 days before the deadline
2 directors resigning, 2 reappointments (director) and (director) resign · (director) and (director) reappointed6 points ▸
- The capital is divided into 100 shares
- resigns as director, not named in the articles
- resigns as director, not named in the articles
- reappointed as director, not named in the articles
- reappointed as director, not named in the articles
- The registered office is at Cyriel Buyssestraat 10, 9000 Gent
- The deed holds 5 more points.
2023
Liquidity more than doubled current ratio 15.79 The current ratio rises from 7.01 to 15.79. Short-term debt falls from €57,014 to €22,381.
Annual accounts 2022 filed PDFmicro format · 24 days before the deadline
2022
Back to profit net €156,180 The net result is €156,180, after 3 loss-making years.
Annual accounts 2021 filed PDFmicro format · 39 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 23 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 3 days before the deadline
2019
Annual accounts 2018 filed PDFmicro format · 19 days before the deadline
2018
Back to profit net €10,270 The net result is €10,270, after one loss-making year.
Liquidity more than 6 times current ratio 11.08 The current ratio rises from 1.68 to 11.08. Short-term debt falls from €434,421 to €36,094.
Annual accounts 2017 filed PDFabbreviated format · 20 days before the deadline
Capital decrease of €405,000 to €20,000The capital fell from €425,000 to €20,000 · General meeting of 18-12-20174 points ▸
- General meeting of 18-12-2017
- The capital was reduced by €405,000
- The capital is €20,000
- Article 5 of the articles of association amended
- The deed holds 1 more point.
2017
Weakest financial year net -€71,852 The net result drops to -€71,852, the lowest from 2006 to 2025.
Annual accounts 2016 filed PDFabbreviated format · 3 days before the deadline
2016
Liquidity more than triples current ratio 7.01 The current ratio rises from 2.25 to 7.01. Short-term debt falls from €306,903 to €119,921.
Equity above €1m equity €1.3m ▲28.8% Equity rises from €985,735 to €1.3m.
Annual accounts 2015 filed PDFabbreviated format · 25 days late
2015
Annual accounts 2014 filed PDFabbreviated format · 18 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 27 days before the deadline
2013
Highest result from 2006 to 2025 net €378,947 ▲44.4% The operating result of €569,095 and the net result of €378,947 are both a record.
Capital increase of €405,000 to €425,000The capital rose from €20,000 to €425,000 · holds all the shares4 points ▸
- The capital was increased by €405,000
- holds all the shares
- The capital is €425,000, divided into 100 shares
- Article 5 of the articles of association amended
- The deed holds 5 more points.
Annual accounts 2012 filed PDFabbreviated format · 27 days before the deadline
2012
Liquidity more than doubled current ratio 2.25 The current ratio rises from 1.06 to 2.25. Short-term debt falls from €499,528 to €203,404.
Registered office moved within GhentThe registered office moved from Gustaaf Callierlaan 104 te 9000 Gent to Cyriel Buyssestraat 10 te 9000 Gent · Board meeting of 01-10-20122 points ▸
- Board meeting of 01-10-2012
- The registered office moved to Cyriel Buyssestraat 10 te 9000 Gent
Annual accounts 2011 filed PDFabbreviated format · 26 days before the deadline
2011
Purpose change · Amendment of the articles2 points ▸
- Net-asset statement, 31-12-2010
- Article 3 of the articles of association amended
- The deed holds 4 more points.
Annual accounts 2010 filed PDFabbreviated format · 122 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 40 days before the deadline
2009
Annual accounts 2008 filed PDFabbreviated format · 32 days before the deadline
2008
Annual accounts 2007 filed PDFabbreviated format · 34 days before the deadline
2007
Equity above €500,000 equity €623,641 ▲52.6% With a profit in every financial year since 2006, equity grows to €623,641.
Annual accounts 2006 filed PDFabbreviated format · 28 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2004
Incorporation PDF13 publications in the Belgian Official Gazette, the last on 30-10-2026 · published on 28-06-2004
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
In 2012 the registered office moved within Ghent.1 A capital increase in 2013 brought the capital to €425,000. After a decrease in 2018 the capital stands at €20,000.2 Total assets fell from €849,597 in 2018 to €684,266 in 2025.3 In 2026 PHARMABRIDGE was dissolved and its liquidation closed in a single deed.4